Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3091978 Title: COMPOSITIONS PHARMACEUTIQUES COMPRENANT DE L'IMIQUIMOD POUR LEUR UTILISATION DANS LE TRAITEMENT IN SITU DU CARCINOME DE LA VESSIE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
157023680
WO application number:
EP2015000022
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3091978
WO publication number:
WO2015104219
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
08/01/2015
Grant date:
18/08/2021
EP publication date:
16/11/2016
WO publication date:
16/07/2015
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
18/08/2021
EP B1 publication date:
18/08/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/01/2022
Expiration date (if granted and all annual fees paid):
08/01/2035

Applicant

Name:
Urogen Pharma Ltd.
Legal Form:
From:
18/08/2021
Address:
9 Ha`Tassiya Street, 4365007 Ra`anana, Israel (IL)
To:

Inventor

1

Name:
HOLLDACK, Johanna
Legal Form:
Address:
CH-6815 Melide, Switzerland (CH)

2

Name:
HOLDEN, Stuart
Legal Form:
Address:
Beverly Hills, CA 90210, United States (US)

3

Name:
POZZI, Raffaella
Legal Form:
Address:
I-21020 Brunello, Italy (IT)

Priority

Priority patent number:
PCT/EP2014/000045
Priority date:
10/01/2014
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
A61K 31/4745; A61P 35/00; A61P 13/00; A61P 43/00; A61K 9/00; A61K 47/10; A61K 47/12; A61K 47/40;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2021/16
Publication date:
30/09/2021
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2022/17
Publication date:
03/10/2022
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
202133
Publication date:
18/08/2021
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type